Bill
S 664
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.
2024-2025 Regular Session
Introduced by Carmen Amato and 12 co-sponsors
Bill redirects New Jersey tobacco tax revenue to guarantee $10 million annually for cancer research through a protected, non-lapsing fund.
Referred to Senate Budget and Appropriations Committee